| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |